Search Results - "Vastert, S."

The clinical and experimental treatment of Juvenile Idiopathic Arthritis by Nijhuis, L, Swart, J F, Prakken, B J, van Loosdregt, J, Vastert, S J

“…Summary Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and comprises of multiple subtypes. The most relevant…”
Get full text

How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases by ter Haar, N.M., Jansen, M.H.A., Frenkel, J.F., Vastert, S.J.

“…IL-1 mediated auto-inflammatory diseases are characterised by episodes of unexplained fever, generalized and localized inflammation. The characteristic…”
Get full text

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes by Rosé, Carlos D, Pans, Steven, Casteels, Ingele, Anton, Jordi, Bader-Meunier, Brigitte, Brissaud, Philippe, Cimaz, Roland, Espada, Graciella, Fernandez-Martin, Jorge, Hachulla, Eric, Harjacek, Miroslav, Khubchandani, Raju, Mackensen, Friederike, Merino, Rosa, Naranjo, Antonio, Oliveira-Knupp, Sheila, Pajot, Christine, Russo, Ricardo, Thomée, Caroline, Vastert, Sebastiaan, Wulffraat, Nico, Arostegui, Juan I, Foley, Kevin P, Bertin, John, Wouters, Carine H

“…To report baseline articular, functional and ocular findings of the first international prospective cohort study of Blau syndrome (BS). Three-year,…”
Get full text

Managing juvenile idiopathic arthritis within the context of their life: What we learnt from children and youth living with juvenile idiopathic arthritis and their parents by Currie, G. R., Kennedy, B. L., S. M., Benseler, R. S. M., Yeung, J. F., Swart, S. J., Vastert, N. M., Wulffraat, M. M. A., Kip, MacKean, Gail, Marshall, D. A.

“…Introduction Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children and causes short‐ and long‐term disability. Optimal…”
Get full text

Transcriptional and epigenetic profiling of nutrient-deprived cells to identify novel regulators of autophagy by Peeters, J.G.C., Picavet, L.W., Coenen, S.G.J.M., Mauthe, M., Vervoort, S.J., Mocholi, E., de Heus, C., Klumperman, J., Vastert, S.J., Reggiori, F., Coffer, P.J., Mokry, M., van Loosdregt, J.

“…Macroautophagy (hereafter autophagy) is a lysosomal degradation pathway critical for maintaining cellular homeostasis and viability, and is predominantly…”
Get full text

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis by Boom, V, Anton, J, Lahdenne, P, Quartier, P, Ravelli, A, Wulffraat, N M, Vastert, S J

“…Macrophage activation syndrome (MAS) is a severe and potentially lethal complication of several inflammatory diseases but seems particularly linked to systemic…”
Get full text

Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register by Otten, Marieke H, Anink, Janneke, Prince, Femke H M, Twilt, Marinka, Vastert, S J, ten Cate, Rebecca, Hoppenreijs, Esther P A H, Armbrust, Wineke, Gorter, Simone L, van Pelt, Philomine A, Kamphuis, Sylvia S M, Dolman, Koert M, Swart, Joost F, van den Berg, J Merlijn, Koopman-Keemink, Yvonne, van Rossum, Marion A J, Wulffraat, Nico M, van Suijlekom-Smit, Lisette W A

“…Treatment of juvenile idiopathic arthritis (JIA) has changed dramatically since the introduction of biological agents in 1999. To evaluate trends in…”
Get more information

Systemic Juvenile Idiopathic Arthritis in two children; case report on clinical course, challenges in diagnosis and the role of FDG‐PET/CT‐scan by Sahba, S., Huurnink, A., Van den Berg, J. M., Tuitert, B., Vastert, S. J., Ten Tusscher, G. W.

“…Systemic juvenile idiopathic arthritis (sJIA, also called Still's disease) is a rare childhood auto‐inflammatory disease with significant morbidity. This case…”
Get full text

S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH by Holzinger, D, Fall, N, Grom, A, de Jager, W, Vastert, S, Strippoli, R, Bracaglia, C, Sundberg, E, Horne, A, Ehl, S, De Benedetti, F, Beutel, K, Foell, D

Get full text

The Right Circumscript Populations by Schadenberg, A W.L, Vastert, S J, Jansen, N J.G, Prakken, B J

Get full text

Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis by Ferreira, R A, Vastert, S J, Abinun, M, Foster, H E, Modesto, C, Olivé, T, Kuis, W, Wulffraat, N M

Get full text

The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) by Shakoory, Bita, Geerlinks, Ashley, Wilejto, Marta, Kernan, Kate, Hines, Melissa, Romano, Micol, Piskin, David, Ravelli, Angelo, Sinha, Rashmi, Aletaha, Daniel, Allen, Carl, Bassiri, Hamid, Behrens, Edward M, Carcillo, Joseph, Carl, Linda, Chatham, Winn, Cohen, Jeffrey I, Cron, Randy Q, Drewniak, Erik, Grom, Alexei A, Henderson, Lauren A, Horne, Annacarin, Jordan, Michael B, Nichols, Kim E, Schulert, Grant, Vastert, Sebastiaan, Demirkaya, Erkan, Goldbach-Mansky, Raphaela, de Benedetti, Fabrizio, Marsh, Rebecca A, Canna, Scott W

“…Haemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening systemic hyperinflammatory syndromes that can develop…”
Get more information

Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series by Sarens, Inge L., Casteels, Ingele, Anton, Jordi, Bader-Meunier, Brigitte, Brissaud, Philippe, Chédeville, Gaelle, Cimaz, Rolando, Dick, Andrew D., Espada, Graciella, Fernandez-Martin, Jorge, Guly, Catherine M., Hachulla, Eric, Harjacek, Miroslav, Khubchandani, Raju, Mackensen, Friederike, Merino, Rosa, Modesto, Consuelo, Naranjo, Antonio, Oliveira-Knupp, Sheila, Özen, Seza, Pajot, Christine, Ramanan, Athimalaipet V., Russo, Ricardo, Susic, Gordana, Thatayatikom, Akaluck, Thomée, Caroline, Vastert, Sebastiaan, Bertin, John, Arostegui, Juan I., Rose, Carlos D., Wouters, Carine H.

“…Provide baseline and preliminary follow-up results in a 5-year longitudinal study of Blau syndrome. Multicenter, prospective interventional case series…”
Get full text

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS) by Shakoory, Bita, Geerlinks, Ashley, Wilejto, Marta, Kernan, Kate, Hines, Melissa, Romano, Micol, Piskin, David, Ravelli, Angelo, Sinha, Rashmi, Aletaha, Daniel, Allen, Carl, Bassiri, Hamid, Behrens, Edward M, Carcillo, Joseph, Carl, Linda, Chatham, Winn, Cohen, Jeffrey I, Cron, Randy Q, Drewniak, Erik, Grom, Alexei A, Henderson, Lauren A, Horne, Annacarin, Jordan, Michael B, Nichols, Kim E, Schulert, Grant, Vastert, Sebastiaan, Demirkaya, Erkan, Goldbach-Mansky, Raphaela, de Benedetti, Fabrizio, Marsh, Rebecca A, Canna, Scott W

“…Haemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening systemic hyperinflammatory syndromes that can develop…”
Get full text

Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis by Bulatović Calasan, Maja, de Vries, Lara D, Vastert, Sebastiaan J, Heijstek, Marloes W, Wulffraat, Nico M

“…The objectives of this study were to assess 27-joint Juvenile Arthritis Disease Activity Score (JADAS-27) responsiveness, JADAS-27 changes corresponding to…”
Get full text

Systemic Juvenile Idiopathic Arthritis Associated Lung Disease in Europe by Bracaglia, C, Minoia, F, Kessel, C, Vastert, S, Pardeo, M, Arduini, A, Fingerhutova, S, Nikishina, I, Basaran, O, Kiper, N, Kostik, M, Glerup, M, Caorsi, R, Horne, A, Filocamo, G, Wittkowski, H, Jelusic, M, Anton, J, Khaldi-Plassart, S, Belot, A, Horneff, G, Sarrott, SP, Schneider, EC, Fotis, L, Dolezalova, P, Ravelli, A, Ozen, S, De Benedetti, F

Get full text

Biologic treatment of pediatric rheumatic diseases: are we spoilt for choice? by van Royen-Kerkhof, Annet, Vastert, Bas Sj, Swart, Joost F, Wulffraat, Nico M

Get more information

Systemic Juvenile Idiopathic Arthritis Associated Lung Disease in Europe by Bracaglia, C, Minoia, F, Kessel, C, Vastert, S, Pardeo, M, Arduini, A, Basaran, O, Kiper, N, Kostik, M, Glerup, M, Fingerhutova, S, Caorsi, R, Horne, A, Filocamo, G, Wittkowski, H, Jelusic, M, Anton, J, Khaldi-Plassart, S, Belot, A, Horneff, G, Sarott, SP, Schneider, EC, Dolezalova, P, Ravelli, A, Ozen, S, De Benedetti, F

Get full text

PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis by Wehrens, E, Vastert, S, Mijnheer, G, Meerding, J, Klein, M, Wulffraat, N, Prakken, B, van Wijk, F

Get full text

PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis by Vastert, S, Bulatovic-Calasan, M, Scholman, R, Klein, M, Wulffraat, N, Prakken, B, Wijk, FV

Get full text